Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Application

A Notice by the Drug Enforcement Administration on 03/15/2004

Document Details

Information about this document as published in the Federal Register.

Printed version:
PDF
Publication Date:
03/15/2004
Agencies:
Drug Enforcement Administration
Document Type:
Notice
Document Citation:
69 FR 12179
Page:
12179 (1 page)
Document Number:
04-5778
Document Details
Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Page views:
0
as of 12/15/2018 at 6:15 pm EST
Document Statistics
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 20, 2004, Lin Zhi International, Inc., 687 North Pastoria Avenue, Sunnyvale, California 94085, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below.

DrugSchedule
Tetrahydrocannabinols (7370)I
3,4-Methylenedioxymethamphetamine (7405)I
Amphetamine (1100)II
Methamphetamine (1105)II
Secobarbital (2315)II
Phencyclidine (7471)II
Cocaine (9041)II
Benzoylecgonine (9180)II
Methadone (9250)II
Dextropropoxyphene (9273)II
Morphine (9300)II

The firm plans to manufacture small quantities of controlled substances to make drug testing reagents and controls.

Any other such applicant and any person who is presently registered with DEA to manufacture such substance may file comments or objections to the issuance of the proposed registration.

Any such comments or objections may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: Federal Register Representative, Office of Chief Counsel (CCD) and must be filed no later than May 14, 2004.

Start Signature

Dated: March 5, 2004.

William J. Walker,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 04-5778 Filed 3-12-04; 8:45 am]

BILLING CODE 4410-09-M

Published Document